✔️ SB170
Regards investigational treatments for certain illnesses
Summary
The bill allows eligible patients with life-threatening or severely debilitating illnesses to request individualized investigational treatments from eligible facilities or manufacturers. It establishes criteria for eligibility, informed consent requirements, and clarifies that manufacturers are not obligated to provide these treatments. Additionally, it protects physicians from penalties for recommending such treatments and states that patients are responsible for associated costs.
Rationale
The bill supports individual rights to access investigational treatments, aligning with the Libertarian principles of self-ownership and personal liberty. It allows patients to make informed choices about their health care, which is consistent with the Libertarian Party's emphasis on personal responsibility and freedom from government interference. However, the requirement for informed consent and the potential for costs to be borne by patients may introduce some limitations on access.
Risks and Concerns
- Potential financial burden on patients for investigational treatments
- Informed consent process may be complex and burdensome
- Manufacturers are not required to provide treatments, limiting access